PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsLarge b-cell lymphoma diffuse
MeSH D016403 - large b-cell lymphoma diffuse
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016393:B-cell lymphoma
15 Companies
7 Drugs
$
Success rate
D016403: 
Large b-cell lymphoma diffuse
11 Companies
8 Drugs
$
Success rate
D000069293:Plasmablastic lymphoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieEpcoritamab Tepkinly  2023-09-22   
ADC TherapeuticsLoncastuximab tesirine Zynlonta  2021-04-23   
Bristol Myers SquibbLisocabtagene maraleucel Breyanzi  2022-04-04 $585 M Q4/23-Q3/24 
GenentechPolatuzumab vedotin Polivy  2019-06-10   
Glofitamab Columvi  2023-06-15   
GenmabEpcoritamab Epkinly  2023-05-19   
Gilead SciencesAxicabtagene ciloleucel Yescarta  2018-08-23 $1,549 M Q4/23-Q3/24 
IncyteTafasitamab Minjuvi  2021-08-26 $37.057 M Y2023 
MorphoSysTafasitamab Monjuvi  2020-07-31   
NovartisTisagenlecleucel Kymriah  2018-08-22 $525 M Q2/21-Q2/24 
Orphan MedicalLoncastuximab tesirine Zynlonta  2022-12-20   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
80%
130/162
Phase 2
39%
73/186
Phase 3
24%
22/91
Approved: 9Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Epcoritamab,
Doconexent,
Sodium lactate,
Muromonab-cd3,
Palifosfamide,
TAPOTOCLAX,
Microcrystalline cellulose,
Anthracycline,
Caelyx,
Doxorubin,
Ibi301,
Iphosphamid,
Vp16,
Gemox,
Arm1,
Hydroxydaunomycin,
Pcd,
Arm2,
Cc5013,
Cmab819,
Abt199,
Tqb2303
ADC Therapeutics
Loncastuximab tesirine,
Sodium lactate,
Bevifimod,
Loncastuximab,
Microcrystalline cellulose,
Caelyx,
Doxorubin,
Ibi301,
Q2w,
Vp16,
Gemox,
Hydroxydaunomycin,
Tqb2303
Bristol Myers Squibb
Lisocabtagene maraleucel,
Sodium lactate,
Bevifimod,
ULOCUPLUMAB,
Microcrystalline cellulose,
Caelyx,
Doxorubin,
Ibi301,
Vp16,
Hsct,
Arm1,
Hydroxydaunomycin,
Arm2,
Bolus,
Cc5013,
Cmab819,
Abt199,
Tqb2303
Genentech
Polatuzumab vedotin,
POLATUZUMAB VEDOTIN-PIIQ,
Glofitamab,
Transplatin,
Tbo-filgrastim,
Fenebrutinib,
Navitoclax,
Lenograstim,
Ademetionine,
Imgatuzumab,
Sodium lactate,
Aspartame,
Bevifimod,
DACETUZUMAB,
Muromonab-cd3,
Palifosfamide,
PINATUZUMAB VEDOTIN,
TAPOTOCLAX,
Microcrystalline cellulose,
Caelyx,
Doxorubin,
Iphosphamid,
Vp16,
Chp,
Gcsf,
Solumedrol,
Hsct,
Gdp,
Hydroxydaunomycin,
Bolus,
Cc5013,
Mephedrone,
Abt199,
Sominex
Genmab
Epcoritamab,
Transplatin,
Vitamin e,
Doconexent,
Sodium lactate,
Muromonab-cd3,
Palifosfamide,
Microcrystalline cellulose,
Anthracycline,
Caelyx,
Doxorubin,
Iphosphamid,
Vp16,
Gemox,
Hsct,
Arm1,
Gdp,
Gemcis,
Hydroxydaunomycin,
Arm2,
Cc5013
Gilead Sciences
Axicabtagene ciloleucel,
Transplatin,
Entospletinib,
Zimberelimab,
Epratuzumab,
Ademetionine,
LANRAPLENIB,
Sodium lactate,
Aspartame,
Palifosfamide,
Veltuzumab,
Microcrystalline cellulose,
Corticoids,
Caelyx,
Doxorubin,
Iphosphamid,
Hdmp,
Vp16,
Solumedrol,
Hsct,
Sdd,
Beam,
Gdp,
Hydroxydaunomycin,
Evidence
Incyte
Tafasitamab,
TAFASITAMAB-CXIX,
Parsaclisib,
Itacitinib,
Sodium chloride,
Bevifimod,
Caelyx,
Doxorubin,
INCB053914,
Solumedrol,
Hsct,
Hydroxydaunomycin,
Cc5013
MorphoSys
Tafasitamab,
Hsct,
Cc5013
Novartis
Tisagenlecleucel,
Benzocaine,
Aglatimagene besadenovec,
Tozadenant,
Spartalizumab,
Buparlisib,
Ademetionine,
Vatalanib,
Doconexent,
Ianalumab,
Bevifimod,
Dulanermin,
IERAMILIMAB,
SOTRASTAURIN,
NIR178,
Mk3475,
MIK665,
Hsct,
Cc5013,
Evidence
Orphan Medical
Sodium lactate,
Microcrystalline cellulose
Roche
Polatuzumab vedotin,
Glofitamab,
Transplatin,
Tbo-filgrastim,
Rimiducid,
Idasanutlin,
Lenograstim,
Ademetionine,
Edrecolomab,
Calcium dobesilate,
Terfenadine,
Vindesine,
Fludeoxyglucose f-18,
Sodium chloride,
Sodium lactate,
Aspartame,
Bevifimod,
Palifosfamide,
Microcrystalline cellulose,
Corticoids,
Caelyx,
Cvp,
Rituxumab,
Doxorubin,
Iphosphamid,
RO6870810,
Vp16,
Chp,
Gcsf,
Gemox,
Solumedrol,
Hsct,
Arm1,
Beam,
Hydroxydaunomycin,
Arm2,
Bolus,
Cc5013,
Evidence,
Abt199,
Sominex
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use